Literature DB >> 11523014

[Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction].

B E Strauer1, M Brehm, T Zeus, N Gattermann, A Hernandez, R V Sorg, G Kögler, P Wernet.   

Abstract

OBJECTIVE: The regenerative potential of human autologous adult stem cells on myocardial regeneration and neovascularisation after myocardial infarction may contribute to healing of the infarction area. But no clinical application has previously been reported. We here describe for the first time the results of this method applied in a patient who had sustained an acute myocardial infarction. HISTORY AND CLINICAL
FINDINGS: 14 hours after the onset of left precordial pain a 46-year-old man was admitted to our hospital for interventional diagnosis and treatment. Coronary angiography demonstrated occlusion of the anterior descending branch of the left coronary artery with transmural infarction. This was treated by percutaneous transluminal catheter angioplasty and stent placement. THERAPY AND
RESULTS: Mononuclear bone marrow cells of the patient were prepared and 6 days after infaction 1,2 infinity 107 cells were transplanted at low pressure via a percutaneous transluminal catheter placed in the infarct-related artery. Before and 10 weeks after this procedure left ventricular function, infarct size, ventricular geometry and myocardial perfusion were measured by (201)thallium SPECT both at rest and on exercise, together with bull's-eye analysis, dobutamine stress echocardiography, right heart catheterisation and radionuclide ventriculography. At 10 weeks after the stem cell transplantation the transmural infarct area had been reduced from 24.6 % to 15.7 % of left ventricular circumference, while ejection fraction, cardiac index and stroke volume had increased by 20-30 %. On exercise the end diastolic volume had decreased by 30 % and there was a comparable fall in left ventricular filling pressure (mean pulmonary capillary pressure).
CONCLUSION: These results for the first time demonstrate that selective intracoronary transplantation of human autologous adult stem cells is possible under clinical conditions and that it can lead to regeneration of the myocardial scar after transmural infarction. The therapeutic effects may be ascribed to stem cell-associated myocardial regeneration and neovascularisation.

Entities:  

Mesh:

Year:  2001        PMID: 11523014     DOI: 10.1055/s-2001-16579-2

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  63 in total

Review 1.  The new stem cell biology: something for everyone.

Authors:  S L Preston; M R Alison; S J Forbes; N C Direkze; R Poulsom; N A Wright
Journal:  Mol Pathol       Date:  2003-04

Review 2.  Protein localization in the plant Golgi apparatus and the trans-Golgi network.

Authors:  C Saint-Jore-Dupas; V Gomord; N Paris
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

Review 3.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

Review 4.  Bone marrow cells and myocardial regeneration.

Authors:  Fu-Sheng Wang; Cathy Trester
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

Review 5.  Protein NMR in biomedical research.

Authors:  W Jahnke; H Widmer
Journal:  Cell Mol Life Sci       Date:  2004-02-26       Impact factor: 9.261

Review 6.  Cell delivery routes for stem cell therapy to the heart: current and future approaches.

Authors:  Niall G Campbell; Ken Suzuki
Journal:  J Cardiovasc Transl Res       Date:  2012-05-31       Impact factor: 4.132

7.  [Clinical perspectives of heart muscle regeneration by stem cells: a future-oriented epilogue].

Authors:  B E Strauer
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

8.  Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity.

Authors:  H Rupp; T P Rupp; P Alter; N Jung; S Pankuweit; B Maisch
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

9.  The survey on cellular and engineered tissue therapies in Europe in 2011.

Authors:  Ivan Martin; Helen Baldomero; Chiara Bocelli-Tyndall; Maximilian Y Emmert; Simon P Hoerstrup; Hilary Ireland; Jakob Passweg; Alan Tyndall
Journal:  Tissue Eng Part A       Date:  2013-11-08       Impact factor: 3.845

Review 10.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.